Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 4
1957 1
1962 3
1963 3
1964 3
1966 3
1967 3
1968 2
1969 7
1970 3
1971 3
1972 1
1973 1
1975 4
1976 6
1977 8
1978 9
1979 3
1980 2
1981 3
1982 3
1983 9
1984 11
1985 17
1986 7
1987 11
1988 14
1989 15
1990 18
1991 11
1992 18
1993 17
1994 14
1995 23
1996 26
1997 30
1998 27
1999 20
2000 23
2001 29
2002 29
2003 40
2004 41
2005 30
2006 30
2007 51
2008 43
2009 38
2010 40
2011 69
2012 56
2013 56
2014 70
2015 74
2016 91
2017 60
2018 79
2019 72
2020 89
2021 90
2022 87
2023 82
2024 82

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,665 results

Results by year

Filters applied: . Clear all
Page 1
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
Komura K, Hirosuna K, Tokushige S, Tsujino T, Nishimura K, Ishida M, Hayashi T, Ura A, Ohno T, Yamazaki S, Nakamori K, Kinoshita S, Maenosono R, Ajiro M, Yoshikawa Y, Takai T, Tsutsumi T, Taniguchi K, Tanaka T, Takahara K, Konuma T, Inamoto T, Hirose Y, Ono F, Shiraishi Y, Yoshimi A, Azuma H. Komura K, et al. Among authors: hirose y. Mol Cancer. 2023 Nov 18;22(1):185. doi: 10.1186/s12943-023-01897-6. Mol Cancer. 2023. PMID: 37980528 Free PMC article.
Tertiary lymphoid structure and neutrophil-lymphocyte ratio coordinately predict outcome of pembrolizumab.
Komura K, Tokushige S, Ishida M, Hirosuna K, Yamazaki S, Nishimura K, Ajiro M, Ohno T, Nakamori K, Kinoshita S, Tsujino T, Maenosono R, Yoshikawa Y, Takai T, Tsutsumi T, Taniguchi K, Tanaka T, Takahara K, Inamoto T, Hirose Y, Ono F, Shiraishi Y, Yoshimi A, Azuma H. Komura K, et al. Among authors: hirose y. Cancer Sci. 2023 Dec;114(12):4622-4631. doi: 10.1111/cas.15976. Epub 2023 Sep 26. Cancer Sci. 2023. PMID: 37752769 Free PMC article.
Current and Future Drug Treatments for Glioblastomas.
Ohba S, Hirose Y. Ohba S, et al. Among authors: hirose y. Curr Med Chem. 2016;23(38):4309-4316. doi: 10.2174/0929867323666161014132907. Curr Med Chem. 2016. PMID: 27758718 Review.
Infusions of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produce antidepressant-like effects on learned helplessness rats through BDNF-TrkB signaling and AMPA receptor activation, and strengthen learning ability.
Shirayama Y, Iwata M, Miyano K, Hirose Y, Oda Y, Fujita Y, Hashimoto K. Shirayama Y, et al. Among authors: hirose y. Brain Res. 2023 Dec 15;1821:148567. doi: 10.1016/j.brainres.2023.148567. Epub 2023 Sep 7. Brain Res. 2023. PMID: 37689333
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma.
Nishimura K, Takahara K, Komura K, Ishida M, Hirosuna K, Maenosono R, Ajiro M, Sakamoto M, Iwatsuki K, Nakajima Y, Tsujino T, Taniguchi K, Tanaka T, Inamoto T, Hirose Y, Ono F, Kondo Y, Yoshimi A, Azuma H. Nishimura K, et al. Among authors: hirose y. NPJ Precis Oncol. 2024 Sep 17;8(1):206. doi: 10.1038/s41698-024-00707-6. NPJ Precis Oncol. 2024. PMID: 39289546 Free PMC article.
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.
Lucocq J, Hawkyard J, Haugk B, Mownah O, Menon K, Furukawa T, Inoue Y, Hirose Y, Sasahira N, Feretis M, Balakrishnan A, Ceresa C, Davidson B, Pande R, Dasari B, Tanno L, Karavias D, Helliwell J, Young A, Nunes Q, Urbonas T, Silva M, Gordon-Weeks A, Barrie J, Gomez D, Van Laarhoven S, Robertson F, Nawara H, Doyle J, Bhogal R, Harrison E, Roalso M, Ciprani D, Aroori S, Ratnayake B, Koea J, Capurso G, Bellotti R, Stättner S, Alsaoudi T, Bhardwaj N, Rajesh S, Jeffery F, Connor S, Cameron A, Jamieson N, Sheen A, Mittal A, Samra J, Gill A, Roberts K, Søreide K, Pandanaboyana S. Lucocq J, et al. Among authors: hirose y. Br J Surg. 2024 Apr 3;111(4):znae100. doi: 10.1093/bjs/znae100. Br J Surg. 2024. PMID: 38659247
New heavy-fermion antiferromagnet UPd2Cd20.
Hirose Y, Doto H, Honda F, Li D, Aoki D, Haga Y, Settai R. Hirose Y, et al. J Phys Condens Matter. 2016 Oct 26;28(42):425601. doi: 10.1088/0953-8984/28/42/425601. Epub 2016 Aug 19. J Phys Condens Matter. 2016. PMID: 27541709
1,665 results